Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 835

1.

Quantity and quality of antibodies after acellular versus whole cell pertussis vaccines in infants born to mothers who received Tdap during pregnancy: a randomised trial.

Wanlapakorn N, Maertens K, Vongpunsawad S, Peunpa J, Tran TMP, Hens N, Van Damme P, Thiriard A, Raze D, Locht C, Poovorawan Y, Leuridan E.

Clin Infect Dis. 2019 Aug 16. pii: ciz778. doi: 10.1093/cid/ciz778. [Epub ahead of print]

PMID:
31418814
2.

Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017.

Koc Ö, Van Damme P, Busschots D, Bielen R, Forier A, Nevens F, Robaeys G.

Euro Surveill. 2019 Jul;24(30). doi: 10.2807/1560-7917.ES.2019.24.30.1900064.

3.

Letter to the editor: female sex workers and HPV vaccine.

Schim van der Loeff MF, Vorsters A, Marra E, Van Damme P, Hogewoning A.

Hum Vaccin Immunother. 2019 Jul 26:1-2. doi: 10.1080/21645515.2019.1643679. [Epub ahead of print]

PMID:
31348738
4.

Poliopolis.

Van Damme P, De Coster I, Revets H, Bandyopadhyay AS.

Lancet. 2019 Jul 13;394(10193):115. doi: 10.1016/S0140-6736(19)31516-8. Epub 2019 Jul 11. No abstract available.

PMID:
31305249
5.

Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis.

Rué L, Oeckl P, Timmers M, Lenaerts A, van der Vos J, Smolders S, Poppe L, de Boer A, Van Den Bosch L, Van Damme P, Weishaupt JH, Ludolph AC, Otto M, Robberecht W, Lemmens R.

Acta Neuropathol Commun. 2019 Jul 12;7(1):114. doi: 10.1186/s40478-019-0759-6.

6.

Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model.

Rossaert E, Pollari E, Jaspers T, Van Helleputte L, Jarpe M, Van Damme P, De Bock K, Moisse M, Van Den Bosch L.

Acta Neuropathol Commun. 2019 Jul 5;7(1):107. doi: 10.1186/s40478-019-0750-2.

7.

Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?

Gille B, De Schaepdryver M, Dedeene L, Goossens J, Claeys KG, Van Den Bosch L, Tournoy J, Van Damme P, Poesen K.

J Neurol Neurosurg Psychiatry. 2019 Jun 7. pii: jnnp-2018-319586. doi: 10.1136/jnnp-2018-319586. [Epub ahead of print]

PMID:
31175169
8.

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.

Van Damme P, De Coster I, Bandyopadhyay AS, Revets H, Withanage K, De Smedt P, Suykens L, Oberste MS, Weldon WC, Costa-Clemens SA, Clemens R, Modlin J, Weiner AJ, Macadam AJ, Andino R, Kew OM, Konopka-Anstadt JL, Burns CC, Konz J, Wahid R, Gast C.

Lancet. 2019 Jul 13;394(10193):148-158. doi: 10.1016/S0140-6736(19)31279-6. Epub 2019 Jun 4.

9.

First-void urine as a non-invasive liquid biopsy source to detect vaccine-induced human papillomavirus antibodies originating from cervicovaginal secretions.

Van Keer S, Willhauck-Fleckenstein M, Pattyn J, Butt J, Tjalma WAA, Van Ostade X, Hens N, Van Damme P, Waterboer T, Vorsters A.

J Clin Virol. 2019 Aug;117:11-18. doi: 10.1016/j.jcv.2019.05.004. Epub 2019 May 11.

10.

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.

Howard JF Jr, Bril V, Burns TM, Mantegazza R, Bilinska M, Szczudlik A, Beydoun S, Garrido FJRR, Piehl F, Rottoli M, Van Damme P, Vu T, Evoli A, Freimer M, Mozaffar T, Ward ES, Dreier T, Ulrichts P, Verschueren K, Guglietta A, de Haard H, Leupin N, Verschuuren JJGM; Efgartigimod MG Study Group.

Neurology. 2019 Jun 4;92(23):e2661-e2673. doi: 10.1212/WNL.0000000000007600. Epub 2019 May 22.

PMID:
31118245
11.

HPV vaccination coverage in the federal state of Belgium according to regions and their impact.

Tjalma W, Brasseur C, Top G, Ribesse N, Morales I, Van Damme PA.

Facts Views Vis Obgyn. 2018 Jun;10(2):101-105.

12.

Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults.

Van Damme P, Dionne M, Leroux-Roels G, Van Der Meeren O, Di Paolo E, Salaun B, Surya Kiran P, Folschweiller N.

J Viral Hepat. 2019 Sep;26(9):1066-1075. doi: 10.1111/jvh.13125. Epub 2019 Jun 2.

PMID:
31087382
13.

Low adherence with national travel medicine recommendations in Belgian expatriate children: A retrospective analysis.

Decuyper II, Van Damme P, Soentjens P, Wojciechowski M.

Travel Med Infect Dis. 2019 May 11. pii: S1477-8939(18)30399-5. doi: 10.1016/j.tmaid.2019.05.010. [Epub ahead of print]

PMID:
31085332
14.

Should female sex workers be offered HPV vaccination?

Schim van der Loeff MF, Vorsters A, Marra E, Van Damme P, Hogewoning A.

Hum Vaccin Immunother. 2019;15(7-8):1544-1548. doi: 10.1080/21645515.2019.1602432. Epub 2019 May 7.

PMID:
31063078
15.

Hepatitis B virus prevalence and risk factors in hard-to-reach Turkish population living in Belgium: A protocol for screening.

Koc ÖM, Hens N, Bielen R, Van Damme P, Robaeys G.

Medicine (Baltimore). 2019 May;98(18):e15412. doi: 10.1097/MD.0000000000015412.

16.

PROTEOFORMER 2.0: Further Developments in the Ribosome Profiling-assisted Proteogenomic Hunt for New Proteoforms.

Verbruggen S, Ndah E, Van Criekinge W, Gessulat S, Kuster B, Wilhelm M, Van Damme P, Menschaert G.

Mol Cell Proteomics. 2019 Aug 9;18(8 suppl 1):S126-S140. doi: 10.1074/mcp.RA118.001218. Epub 2019 Apr 30.

17.

Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine.

Van Damme P, Leroux-Roels G, Vandermeulen C, De Ryck I, Tasciotti A, Dozot M, Moraschini L, Testa M, Arora AK.

Vaccine. 2019 May 21;37(23):3113-3122. doi: 10.1016/j.vaccine.2019.04.041. Epub 2019 Apr 24.

18.

Motor cortex metabolite alterations in amyotrophic lateral sclerosis assessed in vivo using edited and non-edited magnetic resonance spectroscopy.

Weerasekera A, Peeters R, Sima D, Dresselaers T, Sunaert S, De Vocht J, Claeys K, Van Huffel S, Van Damme P, Himmelreich U.

Brain Res. 2019 Sep 1;1718:22-31. doi: 10.1016/j.brainres.2019.04.018. Epub 2019 Apr 16.

PMID:
31002818
19.

An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with Varilrix.

Keersmaekers N, Ogunjimi B, Van Damme P, Beutels P, Hens N.

Vaccine. 2019 May 1;37(19):2537-2553. doi: 10.1016/j.vaccine.2019.03.075. Epub 2019 Apr 8.

PMID:
30975567
20.

Eliminating hepatitis C in Europe.

Lazarus JV, Palayew A, van Damme P, Hendrickx G, Peck R, Colombo M; ACHIEVE European viral hepatitis elimination coalition.

Lancet Gastroenterol Hepatol. 2019 May;4(5):335-336. doi: 10.1016/S2468-1253(19)30082-2. No abstract available.

PMID:
30957750
21.

An ALS case with 38 (G4C2)-repeats in the C9orf72 gene shows TDP-43 and sparse dipeptide repeat protein pathology.

Dedeene L, Van Schoor E, Race V, Moisse M, Vandenberghe R, Poesen K, Van Damme P, Thal DR.

Acta Neuropathol. 2019 May;137(5):855-858. doi: 10.1007/s00401-019-01996-z. Epub 2019 Mar 27. No abstract available.

PMID:
30919029
22.

Tracking the sources of psychrotrophic bacteria contaminating chicken cuts during processing.

Samapundo S, de Baenst I, Aerts M, Cnockaert M, Devlieghere F, Van Damme P.

Food Microbiol. 2019 Aug;81:40-50. doi: 10.1016/j.fm.2018.06.003. Epub 2018 Jun 9.

PMID:
30910087
23.

Ablation of elongation factor 2 kinase enhances heat-shock protein 90 chaperone expression and protects cells under proteotoxic stress.

Xie J, Van Damme P, Fang D, Proud CG.

J Biol Chem. 2019 May 3;294(18):7169-7176. doi: 10.1074/jbc.AC119.008036. Epub 2019 Mar 19.

PMID:
30890561
24.

Microglia lacking a peroxisomal β-oxidation enzyme chronically alter their inflammatory profile without evoking neuronal and behavioral deficits.

Beckers L, Geric I, Stroobants S, Beel S, Van Damme P, D'Hooge R, Baes M.

J Neuroinflammation. 2019 Mar 13;16(1):61. doi: 10.1186/s12974-019-1442-3.

25.

Participatory farm diversification and nutrition education increase dietary diversity in Western Kenya.

Boedecker J, Odhiambo Odour F, Lachat C, Van Damme P, Kennedy G, Termote C.

Matern Child Nutr. 2019 Jul;15(3):e12803. doi: 10.1111/mcn.12803. Epub 2019 Apr 11.

26.

Mutations in the Glycosyltransferase Domain of GLT8D1 Are Associated with Familial Amyotrophic Lateral Sclerosis.

Cooper-Knock J, Moll T, Ramesh T, Castelli L, Beer A, Robins H, Fox I, Niedermoser I, Van Damme P, Moisse M, Robberecht W, Hardiman O, Panades MP, Assialioui A, Mora JS, Basak AN, Morrison KE, Shaw CE, Al-Chalabi A, Landers JE, Wyles M, Heath PR, Higginbottom A, Walsh T, Kazoka M, McDermott CJ, Hautbergue GM, Kirby J, Shaw PJ.

Cell Rep. 2019 Feb 26;26(9):2298-2306.e5. doi: 10.1016/j.celrep.2019.02.006.

27.

FUS (fused in sarcoma) is a component of the cellular response to topoisomerase I-induced DNA breakage and transcriptional stress.

Martinez-Macias MI, Moore DA, Green RL, Gomez-Herreros F, Naumann M, Hermann A, Van Damme P, Hafezparast M, Caldecott KW.

Life Sci Alliance. 2019 Feb 26;2(2). pii: e201800222. doi: 10.26508/lsa.201800222. Print 2019 Apr.

28.

Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoGAA) in treatment-naïve and alglucosidase alfa-treated patients with late-onset Pompe disease: A phase 1, open-label, multicenter, multinational, ascending dose study.

Pena LDM, Barohn RJ, Byrne BJ, Desnuelle C, Goker-Alpan O, Ladha S, Laforêt P, Mengel KE, Pestronk A, Pouget J, Schoser B, Straub V, Trivedi J, Van Damme P, Vissing J, Young P, Kacena K, Shafi R, Thurberg BL, Culm-Merdek K, van der Ploeg AT; NEO1 Investigator Group.

Neuromuscul Disord. 2019 Mar;29(3):167-186. doi: 10.1016/j.nmd.2018.12.004. Epub 2018 Dec 17.

29.

Clinical spectrum of the anti-GQ1b antibody syndrome: a case series of eight patients.

de Bruyn A, Poesen K, Bossuyt X, Heremans IP, Claeys T, Depuydt CE, Van Damme P, Claeys KG.

Acta Neurol Belg. 2019 Mar;119(1):29-36. doi: 10.1007/s13760-019-01093-8. Epub 2019 Feb 12.

PMID:
30747336
30.

Diagnostic and Prognostic Performance of Neurofilaments in ALS.

Poesen K, Van Damme P.

Front Neurol. 2019 Jan 18;9:1167. doi: 10.3389/fneur.2018.01167. eCollection 2018. Review.

31.

Analytical performance of a CE-marked immunoassay to quantify phosphorylated neurofilament heavy chains.

De Schaepdryver M, Goossens J, Jeromin A, Brix B, Van Damme P, Poesen K.

Clin Chem Lab Med. 2019 Jul 26;57(8):e199-e202. doi: 10.1515/cclm-2018-1004. No abstract available.

PMID:
30710472
32.

Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium.

Wouters I, Desmet S, Van Heirstraeten L, Blaizot S, Verhaegen J, Van Damme P, Malhotra-Kumar S, Theeten H; NPcarriage Study Group.

Vaccine. 2019 Feb 14;37(8):1080-1086. doi: 10.1016/j.vaccine.2018.12.068. Epub 2019 Jan 19.

PMID:
30665775
33.

Immunogenicity and safety of intradermal delivery of hepatitis B booster vaccine using the novel drug delivery device VAX-ID™.

Van Mulder TJS, Withanage K, Beyers KCL, Vankerckhoven VVJ, Theeten H, Van Damme P.

Vaccine. 2019 Jan 21;37(4):581-586. doi: 10.1016/j.vaccine.2018.12.016. Epub 2018 Dec 23.

PMID:
30587432
34.

Comparative Immunogenicity and Safety Trial of 2 Different Schedules of Single-visit Intradermal Rabies Postexposure Vaccination.

Soentjens P, De Koninck K, Tsoumanis A, Herssens N, Van Den Bossche D, Terryn S, Van Gucht S, Van Damme P, Van Herrewege Y, Bottieau E.

Clin Infect Dis. 2019 Aug 16;69(5):797-804. doi: 10.1093/cid/ciy983.

PMID:
30566636
35.

Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes.

Devrome M, Van Weehaeghe D, De Vocht J, Van Damme P, Van Laere K, Koole M.

EJNMMI Res. 2018 Dec 13;8(1):110. doi: 10.1186/s13550-018-0458-5.

36.

Human papillomavirus detection in urine: Effect of a first-void urine collection device and timing of collection.

Pattyn J, Van Keer S, Biesmans S, Ieven M, Vanderborght C, Beyers K, Vankerckhoven V, Bruyndonckx R, Van Damme P, Vorsters A.

J Virol Methods. 2019 Feb;264:23-30. doi: 10.1016/j.jviromet.2018.11.008. Epub 2018 Nov 16.

37.

The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs.

Munoz FM, Van Damme P, Dinleyici E, Clarke E, Kampmann B, Heath PT, Levy O, Leuridan E, Cutland C, Sobanjo-Ter Meulen A, Marchant A.

mSphere. 2018 Nov 7;3(6). pii: e00221-18. doi: 10.1128/mSphere.00221-18.

38.

FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins.

Steyaert J, Scheveneels W, Vanneste J, Van Damme P, Robberecht W, Callaerts P, Bogaert E, Van Den Bosch L.

Hum Mol Genet. 2018 Dec 1;27(23):4103-4116. doi: 10.1093/hmg/ddy303.

39.

Non-invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1G93A mouse model: A 1H-magnetic resonance spectroscopic study.

Weerasekera A, Sima DM, Dresselaers T, Van Huffel S, Van Damme P, Himmelreich U.

Neuroimage Clin. 2018;20:1092-1105. doi: 10.1016/j.nicl.2018.09.011. Epub 2018 Sep 19.

40.

Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort.

Tazelaar GHP, Dekker AM, van Vugt JJFA, van der Spek RA, Westeneng HJ, Kool LJBG, Kenna KP, van Rheenen W, Pulit SL, McLaughlin RL, Sproviero W, Iacoangeli A, Hübers A, Brenner D, Morrison KE, Shaw PJ, Shaw CE, Panadés MP, Mora Pardina JS, Glass JD, Hardiman O, Al-Chalabi A, van Damme P, Robberecht W, Landers JE, Ludolph AC, Weishaupt JH, van den Berg LH, Veldink JH, van Es MA; Project MinE ALS Sequencing Consortium.

Neurobiol Aging. 2019 Feb;74:234.e9-234.e15. doi: 10.1016/j.neurobiolaging.2018.09.012. Epub 2018 Sep 22.

PMID:
30342764
41.

Genetic Architecture of Adaptive Immune System Identifies Key Immune Regulators.

Lagou V, Garcia-Perez JE, Smets I, Van Horebeek L, Vandebergh M, Chen L, Mallants K, Prezzemolo T, Hilven K, Humblet-Baron S, Moisse M, Van Damme P, Boeckxstaens G, Bowness P, Dubois B, Dooley J, Liston A, Goris A.

Cell Rep. 2018 Oct 16;25(3):798-810.e6. doi: 10.1016/j.celrep.2018.09.048.

42.

Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice.

Beel S, Herdewyn S, Fazal R, De Decker M, Moisse M, Robberecht W, Van Den Bosch L, Van Damme P.

Mol Neurodegener. 2018 Oct 16;13(1):55. doi: 10.1186/s13024-018-0288-y.

43.

Derivation of norms for the Dutch version of the Edinburgh cognitive and behavioral ALS screen.

Bakker LA, Schröder CD, Spreij LA, Verhaegen M, De Vocht J, Van Damme P, Veldink JH, Visser-Meily JMA, van den Berg LH, Nijboer TCW, van Es MA.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):19-27. doi: 10.1080/21678421.2018.1522352. Epub 2018 Oct 12. Erratum in: Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jan 29;:1.

PMID:
30314420
44.

Relative importance of wildlife and livestock transmission route of brucellosis in southwestern Uganda.

Nina PM, Leirs H, Mugisha S, Van Damme P.

Data Brief. 2018 May 29;19:1080-1085. doi: 10.1016/j.dib.2018.05.135. eCollection 2018 Aug.

45.

Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders.

Bartholomeus E, De Neuter N, Meysman P, Suls A, Keersmaekers N, Elias G, Jansens H, Hens N, Smits E, Van Tendeloo V, Beutels P, Van Damme P, Ogunjimi B, Laukens K, Mortier G.

Vaccine. 2018 Oct 8;36(42):6282-6289. doi: 10.1016/j.vaccine.2018.09.001. Epub 2018 Sep 8.

PMID:
30205979
46.

N-terminal Acetylation Levels Are Maintained During Acetyl-CoA Deficiency in Saccharomyces cerevisiae.

Varland S, Aksnes H, Kryuchkov F, Impens F, Van Haver D, Jonckheere V, Ziegler M, Gevaert K, Van Damme P, Arnesen T.

Mol Cell Proteomics. 2018 Dec;17(12):2309-2323. doi: 10.1074/mcp.RA118.000982. Epub 2018 Aug 27.

47.

Assessment of the timely administration of the hepatitis B and BCG birth dose and the primary infant vaccination schedule in 2015-2016 in the Mekong Delta, Viet Nam.

Pham TT, Le HM, Nguyen DT, Maertens K, Leuridan E, Theeten H, Hendrickx G, Van Damme P.

Vaccine. 2018 Sep 11;36(38):5760-5765. doi: 10.1016/j.vaccine.2018.08.002. Epub 2018 Aug 16.

PMID:
30121141
48.

Altered CD4+ T cell immunity in nurses occupationally exposed to viral pathogens.

Elias G, Souquette A, Heynderickx S, De Meester I, Jansens H, Beutels P, Van Damme P, Smits E, Thomas PG, Van Tendeloo V, Ogunjimi B.

Clin Exp Immunol. 2018 Nov;194(2):192-204. doi: 10.1111/cei.13193. Epub 2018 Sep 19.

PMID:
30076783
49.

HPV immunization programs: Ensuring their sustainability and resilience.

Vorsters A, Van Damme P.

Vaccine. 2018 Aug 23;36(35):5219-5221. doi: 10.1016/j.vaccine.2018.06.066. Epub 2018 Jul 20. No abstract available.

50.

Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration.

García-León JA, Cabrera-Socorro A, Eggermont K, Swijsen A, Terryn J, Fazal R, Nami F, Ordovás L, Quiles A, Lluis F, Serneels L, Wierda K, Sierksma A, Kreir M, Pestana F, Van Damme P, De Strooper B, Thorrez L, Ebneth A, Verfaillie CM.

Alzheimers Dement. 2018 Oct;14(10):1261-1280. doi: 10.1016/j.jalz.2018.05.007. Epub 2018 Jul 20.

Supplemental Content

Loading ...
Support Center